Search results
Novo Nordisk braces for challenge to Ozempic and Wegovy from wave of generics in China
Reuters via Yahoo Finance· 4 days agoSHANGHAI (Reuters) -Novo Nordisk is facing the prospect of intensifying competition in the promising...
Focus Universal Inc. to Attend the IoT Tech Expo North America 2024
Digital Journal· 6 days agoThe newest, fastest-growing and most disruptive newswire available today. More from ACCESSWIRE Silver Spruce Announces Granting of Extension for Closing of Second Tranche ...
Dolby Laboratories Announces Agreement to Acquire GE Licensing from GE Aerospace
Morningstar· 3 days agoAs one of the most respected companies in the field of patent licensing and management, GE Licensing is a leading innovator with world-class patents and ...
DZS Completes NetComm Acquisition
TV Tech· 6 days agoDeal expands its offerings to broadband networking, connectivity and cloud software and its footprint in the Americas, Europe, Middle East, Africa and Australia/New Zealand
Beyond Oil Enters into Supply Agreement with Second Global Fast-Food Chain in Israel
Morningstar· 3 days agoVANCOUVER, BC and KIBBUTZ YIFAT, ISRAEL / ACCESSWIRE / June 6, 2024 / Beyond Oil Ltd. (CSE:BOIL)(OTCQB:BEOLF) ("Beyond Oil" or the "Company"), a food-tech innovation company dedicated to reducing ...
Rihanna is finally launching Fenty Hair: ‘It’s time to play’
Page Six· 5 days agoThe music and makeup mogul has finally announced that she’s expanding her beauty empire with a...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days ago(Unichem) resolving patent litigation related to Axsome’s product Sunosi® (solriamfetol). The litigation, which is pending in the United States District Court for the District ...
Tax Breaks: The Art Of Donating What You Love And Getting A Tax Deduction
Forbes· 2 days agoGary Prebula is different. In 1963, at age 12, he plopped down 12 cents to buy the first issue of The Amazing Spider-Man #1, the character’s solo-debut after Stan Lee introduced the teenage ...
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
Benzinga· 5 days agoNew data from the ELATIVE® Phase III trial show 70% of patients treated with elafibranor achieved composite endpoint of slowing disease progression measured by biochemical response after 78-weeksData from the itch
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoAdvantech Launches Edge AI Server Solutions for Generative AI PR Newswire TAIPEI, June 4, 2024 TAIPEI, June 4, 2024 /PRNewswire/ -- Advantech, a global leader in Industrial IoT, is thrilled to announce a groundbreaking Edge AI server solution for
